INCOME TAXES	6 Months Ended
Mar. 31, 2013
INCOME TAXES [Abstract]
INCOME TAXES	13. INCOME TAXES Our effective income tax rate was 30.4% and 36.4% for the three and six months ended March 31, 2013 compared to a 37.5% and 34.1% effective income tax rate for the three and six months ended March 31, 2012. The increase in the effective tax rate during the first six months of fiscal 2013 was primarily due to the recognition of a $1,686 foreign tax adjustment during the quarter ended December 31, 2012, as discussed in Note 1 under the heading "Results of Operations", and the recognition of a $1,015 valuation allowance on a deferred tax asset during the quarter ended March 31, 2013, related to a former equity investment in an entity that was legally dissolved during the quarter. The former equity investment, which had been fully impaired in fiscal 2007 for financial book purposes, represents a capital asset for tax purposes. Management has determined that it is not likely that capital gains will be generated within the relevant timeframe to offset the capital loss of this investment. Consequently, a valuation allowance has been established to reduce the deferred tax asset to zero. The resulting increase in our effective tax rate was partially offset by effects of the reinstatement of the U.S. research and experimentation tax credit, retroactively effective January 1, 2012, as the American Taxpayer Relief Act of 2012 was signed into law on January 2, 2013. During the quarter ended March 31, 2013, we recorded a $947 discrete tax credit related to qualified research and development spending in fiscal 2012 and we currently estimate we will receive an additional $1,100 in tax benefits for full fiscal year 2013, subject to actual qualified research and development spending as defined by the law.

INCOME TAXES

6 Months Ended

Mar. 31, 2013

13. INCOME TAXES

Our effective income tax rate was 30.4% and 36.4% for the three and six months ended March 31, 2013 compared to a 37.5% and 34.1% effective income tax rate for the three and six months ended March 31, 2012. The increase in the effective tax rate during the first six months of fiscal 2013 was primarily due to the recognition of a $1,686 foreign tax adjustment during the quarter ended December 31, 2012, as discussed in Note 1 under the heading "Results of Operations", and the recognition of a $1,015 valuation allowance on a deferred tax asset during the quarter ended March 31, 2013, related to a former equity investment in an entity that was legally dissolved during the quarter. The former equity investment, which had been fully impaired in fiscal 2007 for financial book purposes, represents a capital asset for tax purposes. Management has determined that it is not likely that capital gains will be generated within the relevant timeframe to offset the capital loss of this investment. Consequently, a valuation allowance has been established to reduce the deferred tax asset to zero. The resulting increase in our effective tax rate was partially offset by effects of the reinstatement of the U.S. research and experimentation tax credit, retroactively effective January 1, 2012, as the American Taxpayer Relief Act of 2012 was signed into law on January 2, 2013. During the quarter ended March 31, 2013, we recorded a $947 discrete tax credit related to qualified research and development spending in fiscal 2012 and we currently estimate we will receive an additional $1,100 in tax benefits for full fiscal year 2013, subject to actual qualified research and development spending as defined by the law.